SEC Form 4/A · accession 0001645627-17-000039

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.

Reporting owner

Officer — President · 10% Owner

Period of report

Apr 18, 2017

Accepted (ET)

Apr 24, 2017 · 1:30 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001528172

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Apr 18, 2017	P	1,000	$0.0646	A	20,218,849	D
Common Stock	Apr 18, 2017	P	1,000	$0.0648	A	20,219,849	D
Common Stock	Apr 18, 2017	P	1,000	$0.0648	A	20,220,849	D
Common Stock	Apr 18, 2017	P	1,000	$0.065	A	20,221,849	D
Common Stock	Apr 18, 2017	P	1,000	$0.063	A	20,222,849	D
Common Stock	Apr 18, 2017	P	1,000	$0.063	A	20,223,849	D
Common Stock	Apr 18, 2017	P	1,000	$0.063	A	20,224,849	D
Common Stock	Apr 18, 2017	P	1,000	$0.0625	A	20,225,849	D
Common Stock	Apr 18, 2017	P	1,000	$0.0625	A	20,226,849	D
Common Stock	Apr 18, 2017	P	1,000	$0.065	A	20,227,849	D
Common Stock	Apr 18, 2017	P	1,000	$0.065	A	20,228,849	D
Common Stock	Apr 18, 2017	P	1,000	$0.065	A	20,229,849	D
Common Stock	Apr 18, 2017	P	1,000	$0.065	A	20,230,849	D
Common Stock	Apr 18, 2017	P	100	$0.065	A	20,230,949	D
Common Stock	Apr 18, 2017	P	1,000	$0.0637	A	20,231,949	D
Common Stock	Apr 18, 2017	P	1,000	$0.0619	A	20,232,949	D
Common Stock	Apr 18, 2017	P	1,000	$0.065	A	20,233,949	D
Common Stock	Apr 18, 2017	P	1,000	$0.0674	A	20,234,949	D
Common Stock	Apr 18, 2017	P	1,000	$0.0668	A	20,235,949	D
Common Stock	Apr 18, 2017	P	1,000	$0.0689	A	20,236,949	D
Common Stock	Apr 18, 2017	P	1,000	$0.07	A	20,237,949	D

No Table II lines on this filing.